FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136133427> ?p ?o ?g. }

• W3136133427 endingPage "811" @default.
• W3136133427 startingPage "811" @default.
• W3136133427 abstract "Mesoporous hydroxyapatite (HA) and iron(III)-doped HA (Fe-HA) are attractive materials for biomedical, catalytic, and environmental applications. In the present study, the nanopowders of HA and Fe-HA with a specific surface area up to 194.5 m2/g were synthesized by a simple precipitation route using iron oxalate as a source of Fe3+ cations. The influence of Fe3+ amount on the phase composition, powders morphology, Brunauer–Emmett–Teller (BET) specific surface area (S), and pore size distribution were investigated, as well as electron paramagnetic resonance and Mössbauer spectroscopy analysis were performed. According to obtained data, the Fe3+ ions were incorporated in the HA lattice, and also amorphous Fe oxides were formed contributed to the gradual increase in the S and pore volume of the powders. The Density Functional Theory calculations supported these findings and revealed Fe3+ inclusion in the crystalline region with the hybridization among Fe-3d and O-2p orbitals and a partly covalent bond formation, whilst the inclusion of Fe oxides assumed crystallinity damage and rather occurred in amorphous regions of HA nanomaterial. In vitro tests based on the MG-63 cell line demonstrated that the introduction of Fe3+ does not cause cytotoxicity and led to the enhanced cytocompatibility of HA." @default.
• W3136133427 created "2021-03-29" @default.
• W3136133427 creator A5003599190 @default.
• W3136133427 creator A5006465665 @default.
• W3136133427 creator A5007102442 @default.
• W3136133427 creator A5018223962 @default.
• W3136133427 creator A5026167684 @default.
• W3136133427 creator A5038076117 @default.
• W3136133427 creator A5041366826 @default.
• W3136133427 creator A5055827004 @default.
• W3136133427 creator A5070748334 @default.
• W3136133427 creator A5071709283 @default.
• W3136133427 creator A5072798772 @default.
• W3136133427 creator A5073844311 @default.
• W3136133427 creator A5074567345 @default.
• W3136133427 creator A5075329423 @default.
• W3136133427 creator A5090060645 @default.
• W3136133427 date "2021-03-22" @default.
• W3136133427 modified "2023-10-01" @default.
• W3136133427 title "Mesoporous Iron(III)-Doped Hydroxyapatite Nanopowders Obtained via Iron Oxalate" @default.
• W3136133427 cites W1548610747 @default.
• W3136133427 cites W1966870542 @default.
• W3136133427 cites W1967385341 @default.
• W3136133427 cites W1976221789 @default.
• W3136133427 cites W1978805977 @default.
• W3136133427 cites W1981368803 @default.
• W3136133427 cites W1997791464 @default.
• W3136133427 cites W1999950824 @default.
• W3136133427 cites W2005902612 @default.
• W3136133427 cites W2018495461 @default.
• W3136133427 cites W2019154888 @default.
• W3136133427 cites W2032407068 @default.
• W3136133427 cites W2033586319 @default.
• W3136133427 cites W2034138577 @default.
• W3136133427 cites W2036113194 @default.
• W3136133427 cites W2043052558 @default.
• W3136133427 cites W2044337020 @default.
• W3136133427 cites W2045596260 @default.
• W3136133427 cites W2052745452 @default.
• W3136133427 cites W2059108930 @default.
• W3136133427 cites W2059359906 @default.
• W3136133427 cites W2068741839 @default.
• W3136133427 cites W2079914197 @default.
• W3136133427 cites W2086771181 @default.
• W3136133427 cites W2087106764 @default.
• W3136133427 cites W2087585288 @default.
• W3136133427 cites W2087709850 @default.
• W3136133427 cites W2088900920 @default.
• W3136133427 cites W2114918609 @default.
• W3136133427 cites W2120145199 @default.
• W3136133427 cites W2123972459 @default.
• W3136133427 cites W2292011412 @default.
• W3136133427 cites W2297756413 @default.
• W3136133427 cites W2312705808 @default.
• W3136133427 cites W2317283500 @default.
• W3136133427 cites W2321106886 @default.
• W3136133427 cites W2327716676 @default.
• W3136133427 cites W2399890704 @default.
• W3136133427 cites W2403636870 @default.
• W3136133427 cites W2461225231 @default.
• W3136133427 cites W2565556421 @default.
• W3136133427 cites W2581772188 @default.
• W3136133427 cites W2594538774 @default.
• W3136133427 cites W2594684238 @default.
• W3136133427 cites W2604153760 @default.
• W3136133427 cites W2605930862 @default.
• W3136133427 cites W2724319349 @default.
• W3136133427 cites W2735933384 @default.
• W3136133427 cites W2737700285 @default.
• W3136133427 cites W2756718256 @default.
• W3136133427 cites W2761685176 @default.
• W3136133427 cites W2791256749 @default.
• W3136133427 cites W2793727629 @default.
• W3136133427 cites W2793984610 @default.
• W3136133427 cites W2794219150 @default.
• W3136133427 cites W2886797449 @default.
• W3136133427 cites W2971428940 @default.
• W3136133427 cites W2979408813 @default.
• W3136133427 cites W2984944315 @default.
• W3136133427 cites W2985532466 @default.
• W3136133427 cites W2993161368 @default.
• W3136133427 cites W2993462268 @default.
• W3136133427 cites W2995786008 @default.
• W3136133427 cites W3003320180 @default.
• W3136133427 cites W3003703757 @default.
• W3136133427 cites W3009845223 @default.
• W3136133427 cites W3013059501 @default.
• W3136133427 cites W3097866978 @default.
• W3136133427 cites W3118690419 @default.
• W3136133427 cites W4206507506 @default.
• W3136133427 cites W4249586237 @default.
• W3136133427 cites W793408817 @default.
• W3136133427 doi "https://doi.org/10.3390/nano11030811" @default.
• W3136133427 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8005114" @default.
• W3136133427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33809993" @default.
• W3136133427 hasPublicationYear "2021" @default.
• W3136133427 type Work @default.
• W3136133427 sameAs 3136133427 @default.

• next